{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:47:19Z","timestamp":1788850039791,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20360"],"award-info":[{"award-number":["U21A20360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271375"],"award-info":[{"award-number":["82271375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province","award":["2022ZQNZD005"],"award-info":[{"award-number":["2022ZQNZD005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00415-024-12443-9","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:01:59Z","timestamp":1716289319000},"page":"4991-5002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1007","volume":"271","author":[{"given":"Lijie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-3945","authenticated-orcid":false,"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"12443_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","volume":"10","author":"N Latov","year":"2014","unstructured":"Latov N (2014) Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol 10:435\u2013446","journal-title":"Nat Rev Neurol"},{"key":"12443_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jns.12455","volume":"26","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. J Peripher Nerv Syst 26:242\u2013268","journal-title":"J Peripher Nerv Syst"},{"key":"12443_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/jnnp-2021-326889","volume":"93","author":"A Uncini","year":"2022","unstructured":"Uncini A, Mathis S, Vallat JM (2022) New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres. J Neurol Neurosurg Psychiatry 93:57\u201367","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12443_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jneuroim.2011.12.023","volume":"244","author":"A Boronat","year":"2012","unstructured":"Boronat A, Sepulveda M, Llufriu S, Sabater L, Blanco Y, Gabilondo I, Sola N, Villoslada P, Dalmau J, Graus F, Saiz A (2012) Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis. J Neuroimmunol 244:103\u2013106","journal-title":"J Neuroimmunol"},{"key":"12443_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","volume":"21","author":"H Pruss","year":"2021","unstructured":"Pruss H (2021) Autoantibodies in neurological disease. Nat Rev Immunol 21:798\u2013813","journal-title":"Nat Rev Immunol"},{"key":"12443_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001098","volume":"9","author":"L Martin-Aguilar","year":"2022","unstructured":"Martin-Aguilar L, Lleixa C, Pascual-Goni E, Caballero-Avila M, Martinez-Martinez L, Diaz-Manera J, Rojas-Garcia R, Cortes-Vicente E, Turon-Sans J, de Luna N, Suarez-Calvet X, Gallardo E, Rajabally Y, Scotton S, Jacobs BC, Baars A, Cortese A, Vegezzi E, Hoftberger R, Zimprich F, Roesler C, Nobile-Orazio E, Liberatore G, Hiew FL, Martinez-Pineiro A, Carvajal A, Pinar-Morales R, Uson-Martin M, Alberti O, Lopez-Perez MA, Marquez F, Pardo-Fernandez J, Munoz-Delgado L, Cabrera-Serrano M, Ortiz N, Bartolome M, Duman O, Bril V, Segura-Chavez D, Pitarokoili K, Steen C, Illa I, Querol L (2022) Clinical and laboratory features in anti-NF155 autoimmune nodopathy. Neurol Neuroimmunol Neuroinflamm 9:e1098","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12443_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN, European Federation of Neurological S, Peripheral Nerve S (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 17:356\u2013363","journal-title":"Eur J Neurol"},{"key":"12443_CR8","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. Eur J Neurol 28:3556\u20133583","journal-title":"Eur J Neurol"},{"key":"12443_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jns.12504","volume":"27","author":"S Arends","year":"2022","unstructured":"Arends S, Drenthen J, Van den Bergh PYK, Hadden RDM, Shahrizaila N, Dimachkie MM, Gutierrez Gutierrez G, Katzberg H, Kiers L, Lehmann HC, Pereon Y, Reisin RC, Uncini A, Verhamme C, Waheed W, Cornblath DR, Jacobs BC (2022) Electrodiagnostic subtyping in Guillain\u2013Barre syndrome: use of criteria in practice based on a survey study in IGOS. J Peripher Nerv Syst 27:197\u2013205","journal-title":"J Peripher Nerv Syst"},{"key":"12443_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/brain\/awy010","volume":"141","author":"R Wilson","year":"2018","unstructured":"Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR (2018) Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica. Brain 141:1063\u20131074","journal-title":"Brain"},{"key":"12443_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1212\/NXI.0000000000000625","volume":"6","author":"S Winklmeier","year":"2019","unstructured":"Winklmeier S, Schluter M, Spadaro M, Thaler FS, Vural A, Gerhards R, Macrini C, Mader S, Kurne A, Inan B, Karabudak R, Ozbay FG, Esendagli G, Hohlfeld R, Kumpfel T, Meinl E (2019) Identification of circulating MOG-specific B cells in patients with MOG antibodies. Neurol Neuroimmunol Neuroinflamm 6:625","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12443_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.25414","volume":"85","author":"FS Thaler","year":"2019","unstructured":"Thaler FS, Thaller AL, Biljecki M, Schuh E, Winklmeier S, Mahler CF, Gerhards R, Volk S, Schnorfeil F, Subklewe M, Hohlfeld R, Kumpfel T, Meinl E (2019) Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders. Ann Neurol 85:448\u2013454","journal-title":"Ann Neurol"},{"key":"12443_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","volume":"96","author":"J Broadley","year":"2019","unstructured":"Broadley J, Seneviratne U, Beech P, Buzzard K, Butzkueven H, O\u2019Brien T, Monif M (2019) Prognosticating autoimmune encephalitis: a systematic review. J Autoimmun 96:24\u201334","journal-title":"J Autoimmun"},{"key":"12443_CR14","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","volume":"90","author":"E Burnor","year":"2018","unstructured":"Burnor E, Yang L, Zhou H, Patterson KR, Quinn C, Reilly MM, Rossor AM, Scherer SS, Lancaster E (2018) Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology 90:e31\u2013e38","journal-title":"Neurology"},{"key":"12443_CR15","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JK Ng","year":"2012","unstructured":"Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Pruss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79:2241\u20132248","journal-title":"Neurology"},{"key":"12443_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","volume":"17","author":"JJ Devaux","year":"2012","unstructured":"Devaux JJ, Odaka M, Yuki N (2012) Nodal proteins are target antigens in Guillain\u2013Barre syndrome. J Peripher Nerv Syst 17:62\u201371","journal-title":"J Peripher Nerv Syst"},{"key":"12443_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu252","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura Y, Shahrizaila N, Yuki N (2015) Biomarkers of \u2018acute-onset\u2019 chronic inflammatory demyelinating polyneuropathy. Brain 138:e335","journal-title":"Brain"},{"key":"12443_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000817","volume":"7","author":"L Appeltshauser","year":"2020","unstructured":"Appeltshauser L, Brunder AM, Heinius A, Kortvelyessy P, Wandinger KP, Junker R, Villmann C, Sommer C, Leypoldt F, Doppler K (2020) Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy. Neurol Neuroimmunol Neuroinflamm 7:e817","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12443_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/brain\/awab014","volume":"144","author":"E Pascual-Goni","year":"2021","unstructured":"Pascual-Goni E, Fehmi J, Lleixa C, Martin-Aguilar L, Devaux J, Hoftberger R, Delmont E, Doppler K, Sommer C, Radunovic A, Carvajal A, Smyth S, Williams L, Mazanec R, Potockova V, Hinds N, Cassereau J, Viala K, Lefilliatre M, Nicolas G, Foley P, Leypoldt F, Keddie S, Lunn MP, Zimprich F, Nunkoo VS, Loscher WN, Martinez-Martinez L, Diaz-Manera J, Rojas-Garcia R, Illa I, Rinaldi S, Querol L (2021) Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy. Brain 144:1183\u20131196","journal-title":"Brain"},{"key":"12443_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.23794","volume":"73","author":"L Querol","year":"2013","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, Martinez-Hernandez E, Diaz-Manera J, Suarez-Calvet X, Navas M, Araque J, Gallardo E, Illa I (2013) Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73:370\u2013380","journal-title":"Ann Neurol"},{"key":"12443_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82:879\u2013886","journal-title":"Neurology"},{"key":"12443_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","volume":"86","author":"K Doppler","year":"2015","unstructured":"Doppler K, Appeltshauser L, Wilhelmi K, Villmann C, Dib-Hajj SD, Waxman SG, Maurer M, Weishaupt A, Sommer C (2015) Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry 86:720\u2013728","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12443_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong AH, Yuki N (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 86:800\u2013807","journal-title":"Neurology"},{"key":"12443_CR24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/brain\/awx124","volume":"140","author":"E Delmont","year":"2017","unstructured":"Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ (2017) Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain 140:1851\u20131858","journal-title":"Brain"},{"key":"12443_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001116","volume":"9","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) IgG4-mediated neurologic autoimmunities: understanding the pathogenicity of IgG4, ineffectiveness of IVIg, and long-lasting benefits of anti-B cell therapies. Neurol Neuroimmunol Neuroinflamm 9:e1116","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12443_CR26","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/brain\/awac418","volume":"146","author":"L Appeltshauser","year":"2023","unstructured":"Appeltshauser L, Junghof H, Messinger J, Linke J, Haarmann A, Ayzenberg I, Baka P, Dorst J, Fisse AL, Gruter T, Hauschildt V, Jork A, Leypoldt F, Maurer M, Meinl E, Michels S, Motte J, Pitarokoili K, Stettner M, Villmann C, Weihrauch M, Welte GS, Zerr I, Heinze KG, Sommer C, Doppler K (2023) Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage. Brain 146:1932\u20131949","journal-title":"Brain"},{"key":"12443_CR27","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1172\/JCI124694","volume":"129","author":"C Manso","year":"2019","unstructured":"Manso C, Querol L, Lleixa C, Poncelet M, Mekaouche M, Vallat JM, Illa I, Devaux JJ (2019) Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo. J Clin Invest 129:2222\u20132236","journal-title":"J Clin Invest"},{"key":"12443_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.779385","volume":"14","author":"Y Gao","year":"2021","unstructured":"Gao Y, Kong L, Liu S, Liu K, Zhu J (2021) Impact of neurofascin on chronic inflammatory demyelinating polyneuropathy via changing the node of ranvier function: a review. Front Mol Neurosci 14:779385","journal-title":"Front Mol Neurosci"},{"key":"12443_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-015-1466-4","volume":"130","author":"EE Ubogu","year":"2015","unstructured":"Ubogu EE (2015) Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathol 130:445\u2013468","journal-title":"Acta Neuropathol"},{"key":"12443_CR30","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/acn3.50931","volume":"6","author":"H Ogata","year":"2019","unstructured":"Ogata H, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Isobe N, Kira JI (2019) Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody. Ann Clin Transl Neurol 6:2304\u20132316","journal-title":"Ann Clin Transl Neurol"},{"key":"12443_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.13561","volume":"1413","author":"MG Huijbers","year":"2018","unstructured":"Huijbers MG, Plomp JJ, van der Maarel SM, Verschuuren JJ (2018) IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. Ann N Y Acad Sci 1413:92\u2013103","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12443-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T15:10:07Z","timestamp":1723475407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["12443"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12443-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol and informed consent procedures received approval from the institutional review boards and ethics committee at the First Affiliated Hospital of Fujian Medical University. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}